Kinetic oscillation stimulation for chronic migraine is associated with a significant decrease in monthly headache days vs ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Read full article: Man in his 50s injured in East Bay Street shooting after argument Read full article: Decca Live music venue one step closer to bringing life to downtown Jacksonville A band of ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...

Read full article: ‘Just hard-working people’: Hundreds gather in Lakewood to protest mass deportation plans Get ready for some fabulous Insider Deals that will help you enjoy a cozy night's ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

This causes pain and other symptoms ... For example, if you have nausea and vomiting with migraine, your doctor may prescribe a nasal spray instead of pills to swallow. You may experience some ...